文献速递淋巴瘤

典型与不典型免疫表型慢性淋巴细胞白血病的细胞遗传学与分子生物学研究

[Study of cytogenetics and molecular biology in typical and atypical immunophenotypic chronic lymphocytic leukemia].
PubMed 文献 · Zhonghua Xue Ye Xue Za Zhi · 2022-01-01

本研究纳入南京医科大学第一附属医院2014年11月至2021年5月收治的488例初诊慢性淋巴细胞白血病(CLL)患者,依据英国马斯登皇家医院免疫分型积分系统分为典型CLL(tCLL,382例)与不典型CLL(aCLL,106例),比较两组免疫表型、遗传学及基因突变差异。aCLL具有特征性免疫表型、细胞遗传学及体细胞突变,有助于两组诊断与鉴别诊断。

要点

  • aCLL的CD10、CD22、CD49d、CD81和FMC7阳性表达率显著高于tCLL。
  • aCLL的+12阳性率显著高于tCLL,del(13q14)阳性率显著低于tCLL。
  • aCLL的NOTCH1突变发生率高于tCLL,两组OS率与TFS率差异无统计学意义。

核心结论

  • aCLL具有不同于tCLL的特征性免疫表型、细胞遗传学及体细胞突变,可为两组诊断和鉴别诊断提供可靠信息。

研究设计与样本

  • 回顾性纳入2014年11月至2021年5月南京医科大学第一附属医院收治的488例初诊CLL患者,按英国马斯登皇家医院免疫分型积分系统分类,积分4~5分为tCLL(382例),积分3分为aCLL(106例)。
  • 采用多参数流式细胞术对488例患者外周血标本进行免疫表型检测,荧光原位杂交(FISH)检测359例患者遗传学异常,二代测序(NGS)检测330例患者基因突变情况。

主要发现

  • aCLL患者CD10、CD22、CD49d、CD81和FMC7阳性表达率显著高于tCLL患者(P值分别为0.020、<0.001、<0.001、0.027和<0.001)。
  • aCLL患者CD5、CD23、CD148和CD200阳性表达率显著低于tCLL患者(P值分别为<0.001、0.017、0.041和<0.001)。
  • aCLL患者+12阳性率显著高于tCLL患者(P<0.001),del(13q14)阳性率显著低于tCLL患者(P<0.001)。
  • aCLL患者NOTCH1突变发生率高于tCLL患者(P=0.038),其余基因突变发生率在两组间的差异均无统计学意义(P值均>0.05)。
  • Kaplan-Meier分析显示,tCLL和aCLL患者总生存(OS)率与无治疗生存(TFS)率的差异无统计学意义(P值均>0.05)。

关键数值与推荐

  • 英国马斯登皇家医院免疫分型积分系统:积分4~5分为典型免疫表型CLL(tCLL),积分3分为不典型免疫表型CLL(aCLL)。

临床怎么用

  • 原文结论认为aCLL的免疫表型、细胞遗传学及体细胞突变特征有助于tCLL与aCLL的诊断和鉴别诊断。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To analyze the differences in immunophenotype, cytogenetics, and molecular biology between typical and atypical immunophenotype chronic lymphocytic leukemia (CLL) , and explore the correlation of cytogenetic anomalies with gene mutations. Methods: This study included 488 patients diagnosed in the First Affiliated Hospital of Nanjing Medical University between November 2014 and May 2021. Of these, 382 patients scored 4-5 points, which was typical CLL (tCLL) , and 106 scored 3 points, which was atypical CLL (aCLL) as per the Royal Marsden Hospital Immunomarker Integral System. Peripheral blood cells were collected for immunophenotype by multiparameter flow cytometry in 488 patients, fluorescence in situ hybridization (FISH) was employed to detect cytogenetic anomalies in 359 patients, and gene mutations were detected by next-generation sequencing (NGS) in 330 patients. Results: The positive rates of CD10, CD22, CD49d, CD81, and FMC7 were significantly higher in the aCLL compared with the tCLL group (P=0.020, P<0.001, P<0.001, P=0.027, and P<0.001, respectively) , while the positive rates of CD5, CD23, CD148, and CD200 were lower in the former compared to the latter (P<0.001, P=0.017, P=0.041, and P<0.001, respectively) . aCLL exhibited a higher frequency of trisomy 12 and lower frequency of del (13q14) compared to the tCLL group (P<0.001 and P<0.001, respectively) . Moreover, aCLL patients also showed a higher incidence of NOTCH1 mutations than the tCLL patients (P=0.038) , while no statistically significant differences in other gene mutations occurred between the two groups. No significant differences in overall survival (OS) and treatment-free survival (TFS) occurred between aCLL and tCLL using Kaplan-Meier analysis (P>0.05) . Conclusion: aCLL has characteristic immunophenotype, cytogenetic, and somatic mutation that differ from tCLL, and this can provide reliable information for the diagnosis and differential diagnosis between the two groups. 目的: 探讨典型和不典型免疫表型慢性淋巴细胞白血病(CLL)在免疫表型、遗传学及分子生物学方面的差异及遗传学异常与基因突变的相关性。 方法: 依据英国马斯登皇家医院免疫分型积分系统对2014年11月至2021年5月期间南京医科大学第一附属医院收治的488例初诊CLL患者进行分类,其中积分4~5分为典型免疫表型CLL(tCLL)(382例),积分3分为不典型免疫表型CLL(aCLL)(106例)。采用多参数流式细胞术对所有CLL患者外周血标本进行免疫表型检测,荧光原位杂交(FISH)技术检测359例CLL患者的遗传学异常,二代测序(NGS)技术检测330例CLL患者基因突变情况。 结果: aCLL患者CD10、CD22、CD49d、CD81和FMC7阳性表达率显著高于tCLL患者(P值分别为0.020、<0.001、<0.001、0.027和<0.001),CD5、CD23、CD148和CD200的阳性表达率显著低于tCLL患者(P值分别为<0.001、0.017、0.041和<0.001)。aCLL患者+12阳性率显著高于tCLL患者(P<0.001),del(13q14)阳性率显著低于tCLL患者(P<0.001),同时aCLL患者NOTCH1突变发生率高于tCLL患者(P=0.038),其余基因突变发生率在两组间的差异均无统计学意义(P值均>0.05)。生存分析显示,tCLL和aCLL患者总生存(OS)率与无治疗生存(TFS)率的差异无统计学意义(P值均>0.05)。 结论: tCLL与aCLL患者的抗原表达特征、细胞遗传学及体细胞突变均存在差异,有助于tCLL与aCLL的诊断和鉴别诊断。.

来源:Zhonghua Xue Ye Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Jin HM, Qiao C, Zhao SS, et al. [Study of cytogenetics and molecular biology in typical and atypical immunophenotypic chronic lymphocytic leukemia]. Zhonghua Xue Ye Xue Za Zhi. 2022. PMID: 35968589. doi:10.3760/cma.j.issn.0253-2727.2022.06.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。